BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26205576)

  • 1. Reply to "Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: How Important are Intrauterine Adhesions?".
    De Marzi P; Bergamini A; Luchini S; Petrone M; Taccagni G; Mangili G; Colombo G; Candiani M
    J Minim Invasive Gynecol; 2015; 22(7):1319. PubMed ID: 26205576
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to "Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: How Important Are Intrauterine Adhesions?".
    De Marzi P; Bergamini A; Luchini S; Petrone M; Taccagni G; Mangili G; Colombo G; Candiani M
    J Minim Invasive Gynecol; 2016; 23(3):454-5. PubMed ID: 26724717
    [No Abstract]   [Full Text] [Related]  

  • 3. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: How Important Are Intrauterine Adhesions?
    Mandato VD; Palomba S; Nucera GS; La Sala GB
    J Minim Invasive Gynecol; 2016; 23(3):453-4. PubMed ID: 26724716
    [No Abstract]   [Full Text] [Related]  

  • 4. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: How Important Are Intrauterine Adhesions?
    Shokeir T
    J Minim Invasive Gynecol; 2015; 22(7):1318. PubMed ID: 26205575
    [No Abstract]   [Full Text] [Related]  

  • 5. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy.
    De Marzi P; Bergamini A; Luchini S; Petrone M; Taccagni GL; Mangili G; Colombo G; Candiani M
    J Minim Invasive Gynecol; 2015; 22(7):1178-82. PubMed ID: 26092080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer.
    Yang B; Xu Y; Zhu Q; Xie L; Shan W; Ning C; Xie B; Shi Y; Luo X; Zhang H; Chen X
    Gynecol Oncol; 2019 Apr; 153(1):55-62. PubMed ID: 30674421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer.
    Falcone F; Laurelli G; Losito S; Di Napoli M; Granata V; Greggi S
    J Gynecol Oncol; 2017 Jan; 28(1):e2. PubMed ID: 27670256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].
    Cao DY; Yu M; Yang JX; Shen K; Huang HF; Cheng NH; Sun ZY; Deng CY; Yu Q; He FF
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):519-22. PubMed ID: 24284224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of hysteroscopic endometrectomy in the conservative treatment of early endometrial cancer and atypical hyperplasia in fertile women.
    Atallah D; El Kassis N; Safi J; El Hachem H; Chahine G; Moubarak M
    Arch Gynecol Obstet; 2021 Nov; 304(5):1299-1305. PubMed ID: 33830345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial.
    Yang BY; Gulinazi Y; Du Y; Ning CC; Cheng YL; Shan WW; Luo XZ; Zhang HW; Zhu Q; Ma FH; Liu J; Sun L; Yu M; Guan J; Chen XJ
    BJOG; 2020 Jun; 127(7):848-857. PubMed ID: 31961463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of operative hysteroscopy conducted before progestin treatment in early stage endometrial cancer from the view of fertility.
    Park H; Seong SJ; Yoon BS
    Gynecol Oncol; 2011 Nov; 123(2):427-8. PubMed ID: 21295336
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic impact of hysteroscopic resection of endometrial atypical hyperplasia-endometrioid intraepithelial neoplasia and early-stage cancer in combination with megestrol acetate.
    Masciullo V; Trivellizzi N; Zannoni G; Catena U; Moroni R; Fanfani F; Scambia G
    Am J Obstet Gynecol; 2021 Apr; 224(4):408-410. PubMed ID: 33385345
    [No Abstract]   [Full Text] [Related]  

  • 13. A prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women.
    Shan BE; Ren YL; Sun JM; Tu XY; Jiang ZX; Ju XZ; Zang RY; Wang HY
    Arch Gynecol Obstet; 2013 Nov; 288(5):1115-23. PubMed ID: 23644919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report.
    Corrado G; Baiocco E; Carosi M; Vizza E
    Fertil Steril; 2008 Nov; 90(5):2006.e5-8. PubMed ID: 18692828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fertility-sparing management of low-grade endometrial stromal sarcoma: analysis of an institutional series and review of the literature.
    Laurelli G; Falcone F; Scaffa C; Messalli EM; Del Giudice M; Losito S; Greggi S
    Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():61-66. PubMed ID: 26476800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review and meta-analysis of prognostic factors for remission in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma.
    Guillon S; Popescu N; Phelippeau J; Koskas M
    Int J Gynaecol Obstet; 2019 Sep; 146(3):277-288. PubMed ID: 31197826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium.
    Yu M; Yang JX; Wu M; Lang JH; Huo Z; Shen K
    Fertil Steril; 2009 Dec; 92(6):2122-4. PubMed ID: 19591991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and pregnancy outcomes of hysteroscopic surgery combined with progestin as fertility-sparing therapy in patients with early stage endometrial cancer and atypical hyperplasia.
    Xi Y; Liu G; Liu D; Jiang J; Gong R
    Arch Gynecol Obstet; 2023 Feb; 307(2):583-590. PubMed ID: 35674831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hysteroscopic biopsy compared with endometrial curettage to assess the preoperative rate of atypical hyperplasia underestimating endometrial carcinoma.
    Garuti G; Sagrada PF; Frigoli A; Fornaciari O; Finco A; Mirra M; Soligo M
    Arch Gynecol Obstet; 2023 Sep; 308(3):971-979. PubMed ID: 37160470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fertility-sparing treatment of endometrial cancer precursors among young women: a reproductive point of view.
    Ricciardi E; Maniglio P; Frega A; Marci R; Caserta D; Moscarini M
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1934-7. PubMed ID: 23242719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.